Funding

NIHR Funding Calls

IIT Awards

The NIHR Clinical Research Network North East and North Cumbria (CRN NENC) recently opened its most recent round of Investigator Initiated Commercially Funded Research Studies (IIT) Funding Awards.

This £5000 award is to support applicants from the North East and North Cumbria (NENC) to develop and lead on an Investigator Initiated Trial (IIT), as well as providing practical support to assist you in achieving Clinical Research Network (CRN) Portfolio status.

Applications are open to anyone involved in health or social care research including previous applicants. Where an award was received in any of the previous years, applicants are expected to outline the next steps and detail how further funding will be used towards a larger study.

Please visit this website for further information, or access the application form here.

i4i Programme

The invention for innovation (i4i) programme is a dedicated MedTech translational funding scheme for academics, clinicians and small- medium-sized enterprises(SME), which will advance innovative medical technologies and interventions for increased patient benefit in areas of existing or emerging clinical need. Projects must have already demonstrated proof of concept as a minimum. Applicants are expected to have generated experimental data to support the case for further development and illustrate technical feasibility, have sufficient research and activities planned (e.g. regulatory or health economics), and have a clear pathway towards adoption and commercialisation. Contact details for queries: i4i@nihr.ac.uk

The Efficacy and Mechanism Evaluation (EME) programme primarily funds clinical trials and other robustly designed studies that test the efficacy of interventions. It covers both new and repurposed interventions, including diagnostic tests and decision-making tools, therapeutics, psychological treatments, medical devices, and public health initiatives delivered by the NHS. EME also supports hypothesis-driven research within clinical trials into the mechanism of action of interventions. Applications are required to demonstrate some initial evidence that the technology may be efficacious in patients (i.e. a signal of efficacy in a relevant human population has already been achieved) but a large-scale study is needed to determine definitive proof of clinical efficacy. Contact details for queries: eme@nihr.ac.uk

The Health Technology Assessment (HTA) programme supports research that is immediately useful to patients, clinical practice, and policy or decision makers. It supports research into a wide range of technologies with the potential to improve health outcomes, including procedures, drugs, devices, diagnostic tests, settings of care and screening programmes. Studies funded by HTA aim to establish the clinical effectiveness or accuracy and cost-effectiveness of technologies in comparison with the current alternative(s) or within existing pathways. Applications to HTA are required to demonstrate that efficacy has already been established. Contact details for queries: htafunding@nihr.ac.uk

22/88 – Repetitive Transcranial Magnetic Stimulation for depression in adolescents

The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic. This funding call is looking for researchers who can establish whether it is feasible to examine the effectiveness of repetitive TMS for adolescents with depression, and if it is feasible, whether this is clinical and cost-effective. Applications close at 13:00 on 30th November 2022. Click for further details and to access the application form.

22/90 – Self-care of children and young people with neurodisability

The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic. The funding call is looking for applications from researchers who can establish the clinical and cost-effectiveness of interventions to improve self-care of children and young people with neurodisability. Applications close at 13:00 on the 30th November 2022. Click for further details and to access the application form.

22/97 – Early detection of liver disease

The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic. This funding call is looking for applications from researchers who can establish the most clinical and cost-effective method of selecting at risk people in primary care for referral to secondary care for management of chronic liver disease. Applications close at 13:00 on 25th January 2023. Click for further details and to access the application form.

22/98 – Low-dose computed tomography for the diagnosis of lung cancer in symptomatic patients seen in primary care

The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic. This funding call is looking for applications from researchers who can assess the feasibility of conducting a study to examine the diagnostic performance of low-dose chest CT in the assessment of patients with symptoms that may suggest lung cancer. Applications close at 13:00 on 25th January 2023. Click for further details and to access the application form.

22/99 – Clinical prediction models for early-onset neonatal infection

The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic. This funding call is looking for applications from researchers who can establish the accuracy of clinical prediction models for early-onset neonatal infection in the UK and establish their effectiveness in guiding management in the baby. Applications close at 13:00 on 25th January 2023. Click for further details and to access the application form.

22/101 – Management of bone metastasis and skeletal related events (SREs) in patients with advanced cancer

The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research or evidence synthesis topic. Applications close at 13:00 on 4th January 2023. Click for further details and to access the application form.

22/112 – Health Technology Assessment Programme researcher-led (primary research)

The Health Technology Assessment (HTA) Programme is accepting stage one applications to this funding opportunity. The HTA Programme aims to commission high-quality, well-designed research which will be carried out by effective and efficient research teams, providing findings which meet the needs of NHS and Social Care managers and leaders. Applications close at 13:00 on 4th January 2023. Click for further details and to access the application form.

22/114 – NIHR NICE rolling call (HTA Programme)

The Health Technology Assessment (HTA) Programme is accepting stage one applications to this funding opportunity. The programme is interested in receiving applications to meet recommendations in research identified in NICE guidance that has been published or updated since 2015. Applications close at 13:00 on 4th January 2023. Click for further details and to access the application form.

22/129 – Motor Neurone Disease highlight notice

The Health Technology Assessment (HTA) Programme is accepting stage one applications to this funding opportunity. This funding call invites proposals for Motor Neurone Disease research to address important health and social care questions. Applications close at 13:00 on 4th January 2023. Click for further details and to access the application form.

Charity grants

Epilepsy Research UK

Emerging Leader Fellowships

Emerging Leader Fellowship awards provide research funding for epilepsy researchers planning to develop a track record in epilepsy research and seeking to transition into research leadership. Funds will cover the Fellow’s salary, support staff costs, and project running costs.
Up to £250,000, over 1-4 years

Closing Date: 22 September 2022

British Heart Foundation

Clinical Study Grants funded by the British Heart Foundation | BHF

For clinical trials and observational studies of specific patient groups, usually costing more than £350,000 or lasting more than 3 years. Preliminary application assessment panel meetings are currently planned to take place in:

  • September 2022 – submit by 5pm Wednesday 14th September 2022
  • November 2022 – submit by 5pm Wednesday 26th October 2022
  • February 2023 – submit by 5pm Wednesday 18th January 2023
  • May 2023 – submit by 5pm Wednesday 3rd May 2023
  • September 2023 – submit by 5pm Wednesday 6th September 2023
  • November 2023 – submit by 5pm Wednesday 25th October 2023

Cancer Research UK

Prevention and Population Research Project Award

Prevention and Population Research Awards provide support for focused research proposals centred on key questions in prevention and population research.
Up to £500,000, up to 3 years

Closing Date: 14 December 2022